Lantech.com, LLC v. Wulftec International Inc., 2018 FC 41

JurisdictionFederal Jurisdiction (Canada)
CourtFederal Court (Canada)
Citation2018 FC 41
Date16 January 2018
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
3 practice notes
  • Post-AstraZeneca: Has The Promise Doctrine Vanished From Patent Litigation? Likely, Yes
    • Canada
    • Mondaq Canada
    • 15 Octubre 2018
    ...of California v. I-MED Pharma Inc, 2018 FC 164; Sernova Corp v. Shapiro, 2018 ONSC 841; Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41; Apotex Inc v. AstraZeneca Canada Inc, 2018 FC 181; Hospira Healthcare Corp v. Kennedy Trust for Rheumatology Research, 2018 FC 3 Apotex Inc. v. ......
  • Update: The Promise Doctrine And Utility Post Astrazeneca
    • Canada
    • Mondaq Canada
    • 28 Marzo 2018
    ...cells which was "a more islet friendly environment" as claimed. [Emphasis Added] Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41 On a motion to re-amend a Statement of Defence and Counterclaim, the Court rejected the Plaintiff's new allegations of inutility grounded in the promise......
  • Specialized Desanders Inc. v. Enercorp Sand Solutions Inc., 2018 FC 689
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • 5 Julio 2018
    ...pleads sufficient material facts to make out the prior disclosure defence. Referencing Lantech.com, LLC v Wulftec International Inc, 2018 FC 41 [Lantech], the Prothonotary states (in the impugned sentence emphasized above) that no supporting material facts are pleaded as to what information......
1 cases
  • Specialized Desanders Inc. v. Enercorp Sand Solutions Inc., 2018 FC 689
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • 5 Julio 2018
    ...pleads sufficient material facts to make out the prior disclosure defence. Referencing Lantech.com, LLC v Wulftec International Inc, 2018 FC 41 [Lantech], the Prothonotary states (in the impugned sentence emphasized above) that no supporting material facts are pleaded as to what information......
2 firm's commentaries
  • Post-AstraZeneca: Has The Promise Doctrine Vanished From Patent Litigation? Likely, Yes
    • Canada
    • Mondaq Canada
    • 15 Octubre 2018
    ...of California v. I-MED Pharma Inc, 2018 FC 164; Sernova Corp v. Shapiro, 2018 ONSC 841; Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41; Apotex Inc v. AstraZeneca Canada Inc, 2018 FC 181; Hospira Healthcare Corp v. Kennedy Trust for Rheumatology Research, 2018 FC 3 Apotex Inc. v. ......
  • Update: The Promise Doctrine And Utility Post Astrazeneca
    • Canada
    • Mondaq Canada
    • 28 Marzo 2018
    ...cells which was "a more islet friendly environment" as claimed. [Emphasis Added] Lantech.com, LLC v. Wulftec International Inc, 2018 FC 41 On a motion to re-amend a Statement of Defence and Counterclaim, the Court rejected the Plaintiff's new allegations of inutility grounded in the promise......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT